Positive opinion for Novo Nordisk’s Sogroya by John Pinching | May 26, 2023 | News | 0 Therapy has been developed for use among children and adolescents with growth hormone deficiency Read More
Novo Nordisk’s Sogroya moves closer towards EU approval by Lucy Parsons | Feb 2, 2021 | News | 0 CHMP recommended marketing authorisation for human growth hormone therapy Read More